-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Rubius Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2016 to 2022.
- Rubius Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2022 was -$1.13M, a 168% decline year-over-year.
- Rubius Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2022 was $3.86M, a 40% decline year-over-year.
- Rubius Therapeutics, Inc. annual Interest Expense for 2022 was $3.86M, a 40% decline from 2021.
- Rubius Therapeutics, Inc. annual Interest Expense for 2021 was $6.43M, a 53.7% increase from 2020.
- Rubius Therapeutics, Inc. annual Interest Expense for 2020 was $4.19M, a 61.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)